封面
市場調查報告書
商品編碼
1247464

2023-2030 年全球導管穩定裝置市場

Global Catheter Stabilization Devices Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

全球導管穩定裝置市場預計到 2022 年將達到 12.31 億美元,在預測期內(2023-2030 年)以 4.5% 的複合年增長率增長。

導管穩定器是一種醫療設備,旨在將導管固定到位並防止其移動或意外移動。 導管是一根細而柔韌的管子,可插入體內以輸送液體、給藥或測量身體機能。 導管插入術是一種常見的醫療程序,用於各種環境,包括醫院、診所和家庭護理。

市場動態

增加導管穩定裝置的益處

在醫院裡,導管是理所當然的。 根據 2021 年發表在《血管通路雜誌》(Journal of Vascular Access) 上的一篇論文,血管裝置的最佳穩定性包含在所有插入束中,是將並發症風險降至最低的重要方法。 血管通路裝置的適當穩定性應確保裝置的完整性,最大限度地減少導管在出口處的移動,並防止導管移位。 市場層提供產品以擴展您的業務。 例如,Eloquest Healthcare, Inc. 提供皮下導管固定裝置 SecurAcath。 該裝置採用了一個小錨(安全腳),它被放置在導管插入部位的皮膚下並連接到導管軸上。

技術進步

導管穩定裝置的技術進步帶來了市場機遇。 例如,Delta Med S.p.A. 提供的無縫線穩定裝置對於提供適當的導管穩定和降低脫位和並發症的風險至關重要。 它易於應用,導管尖端不會移動或移動,沒有意外穿刺的風險,並且沒有硬質部件更舒適。 此外,在固定直 PIV 導管時,與領先的標準薄膜敷料和膠帶相比,3M Tegaderm I.V. Advanced Securement Dressing 1683 和膠帶在 48 小時後能夠承受三倍的拉力。

導管穩定裝置的缺點

皮膚粘附無縫線裝置(與敷料分開或嵌入透明膜中)足夠安全,但有幾個問題:它們必須每週更換;不能 100% 有效地抑制脫落,干擾出口部位的適當消毒,允許導管在出口部位“進出”震顫,並可能導致 MARSI(醫學粘附相關皮膚損傷)。

內容

第 1 章研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章定義和概述

第 3 章執行摘要

  • 按產品分類的片段
  • 按應用程序摘錄
  • 最終用戶的片段
  • 區域摘要

第 4 章動力學

  • 影響因子
    • 司機
      • 技術進步
      • 增加慢性病的患病率
    • 約束因素
      • 備選方案的可用性
    • 機會
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • 在 COVID-19 情景之前
    • 當前的 COVID-19 情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 結論

第 7 章副產品

  • 外周導管固定裝置
    • Foley 導管固定裝置
    • 鼻胃管固定裝置
    • 氣管插管固定裝置
    • 心室腹膜固定裝置
    • 連續神經阻滯導管固定裝置
    • 中線固定裝置
  • 中心靜脈導管固定裝置
    • 入口安全裝置
    • PICC固定裝置
    • 鎖骨下固定裝置
    • 股骨固定裝置
    • 頸動脈固定裝置
  • 動脈導管固定裝置
  • 胸腔引流管固定裝置
  • 腹膜引流管固定裝置
  • 硬膜外固定裝置
  • 整週固定裝置

第八章應用

  • 心血管手術
  • 呼吸程序
  • 胃和口咽手術
  • 普通外科
  • 泌尿外科
  • 放射科
  • 其他用途

第 9 章最終用戶

  • 醫院
  • 門診手術診所
  • 其他

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 俄羅斯
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 競爭場景
  • 市場分析/份額分析
  • 併購分析

第12章公司簡介

  • 歐姆龍公司
    • 公司簡介
    • 產品組合和說明
    • 財務摘要
    • 主要發展
  • Koninklijke Philips N.V
  • 3M
  • Allied Healthcare Products, Inc
  • Becton, Dickinson and Compan
  • Agilent Technologies
  • Medline Industries, Inc.
  • Briggs Healthcare
  • Cathetrix
  • GF Health Products, Inc

第13章 附錄

簡介目錄
Product Code: MD1470

Market Overview

The global catheter stabilization devices market reached US$ 1,231 million in 2022 and is projected to witness lucrative growth by reaching up to US$ XX million by 2030. The market is growing at a CAGR of 4.5% during the forecast period (2023-2030).

Catheter stabilization devices are medical devices that are designed to secure a catheter in place, preventing it from shifting or being accidentally dislodged. Catheters are thin, flexible tubes that are inserted into the body to deliver fluids, and medications, or to measure bodily functions. Catheterization is a common medical procedure that is used in a variety of settings, including hospitals, clinics, and home care.

Market Dynamics

The growing benefits of catheter stabilization devices

Catheters are commonplace in hospital settings. As per the article published in the Journal of Vascular Access in 2021, the optimal stabilization of the vascular device is part of all insertion bundles and is s as an important approach to minimize the risk of complications. Adequate stabilization of a vascular access device must ensure the integrity of the device, minimize the motion of the catheter at the exit site, and prevent the dislodgment of the catheter. The market layers are offering the products to expand their business. For instance, Eloquest Healthcare, Inc. offers SecurAcath a subcutaneous catheter securement system. The device employs a small anchor (securement feet) positioned just beneath the skin at the catheter insertion site and connected to the catheter shaft.

Technological advancements

The technological advances in catheter stabilization devices open opportunities in the market. For instance, sutureless stabilization devices offered by Delta Med S.p.A. which is provided proper stabilization of the catheter are essential to reduce the risk of dislocations and complications. They are easy to apply, they avoid dislocation and migration of the catheter tip, they eliminate the risk of accidental puncture wounds, and they are more comfortable as they have no rigid parts. Also When securing a straight PIV catheter, 3M Tegaderm I.V. Advanced Securement Dressing 1683 plus tape strips withstood three times the pull force after 48 hours of the leading standard film dressing plus tape strip.

The drawbacks of catheter stabilization devices

Skin-adhesive sutureless devices (either separate from the dressing or integrated into the transparent membrane) are sufficient and secure but may have some impediments: they must be replaced weekly; they are not 100% effective in controlling dislodgment; they interfere with adequate disinfection of the exit site; they allow "in and out" micromovements of the catheter at the exit-site, also they might generate MARSI (Medical Adhesive-Related Skin Injury).

Segment Analysis

The global catheter stabilization devices market is segmented based on product, application, end-user, and region.

Owing to their versatility and cost-effectiveness, the peripheral catheter securement devices

Peripheral catheter securement devices are a type of catheter stabilization device that are used specifically to secure peripheral intravenous catheters (PIVCs) in place. PIVCs are short, thin tubes that are inserted into a peripheral vein, typically in the arm or hand, to deliver medications, fluids, or nutrients. PIVCs are commonly used in hospitals, clinics, and other healthcare settings. Peripheral catheter securement devices are designed to hold the PIVC securely in place, preventing it from becoming dislodged or moving around. These devices can be adhesive-based, using tape or similar materials to secure the catheter to the skin, or they can be mechanical-based, using clips or other devices to hold the catheter in place.

Geographical Penetration

The strong presence of major players and technological advancements

The growing demand in developing countries, especially in Europe, creates opportunities for manufacturers to expand their operations in these regions. The increasing chronic disease in the Europe region drives the market. For instance, according to European Chronic Disease Alliance, chronic disease is the main cause of mortality in Europe, representing 77% of the total disease burden and 86% of all deaths. Also, active players are offering catheter stabilization devices in the market. For instance, Bunzl Healthcare (London) offers The Statlcok PICC device, which eliminates the need to secure a catheter with a suture. It secures the catheter in place. and is compatible for use with a wide variety of PICC catheters. It is faster and easier to apply than suture and permits visibility of the insertion site. The foam anchor pad is made from breathable latex-free tricot fabric that delivers added catheter security and patient comfort. The device has sliding pads.

Competitive Landscape

The major global players include Omron Corporation, Koninklijke Philips N.V., 3M, Allied Healthcare Products, Inc., Becton, Dickinson and Company, Agilent Technologies, Medline Industries, Inc., Briggs Healthcare, Cathetrix, GF Health Products, Inc.

COVID-19 Impact Analysis

By Product

  • Peripheral Catheter Securement Devices
    • Foley Catheter Securement Devices
    • Nasogastric Tube Securement Devices
    • Endotracheal Tube Securement Devices
    • Ventriculoperitoneal Securement Devices
    • Continuous Nerve Block Catheter Securement Devices
    • Midlines Securement Devices
  • Central Venous Catheter Securement Devices
    • Portal Securement Devices
    • PICC Securement Devices
    • Subclavian Securement Devices
    • Femoral Securement Devices
    • Jugular Securement Devices
  • Arterial Catheter Securement Devices
  • Chest Drainage Tube Securement Devices
  • Abdominal Drainage Tube Securement Devices
  • Epidural Securement Devices
  • All-Site Securement Devices

By Application

  • Cardiovascular Procedures
  • Respiratory Procedures
  • Gastric and Oropharyngeal Procedures
  • General Surgery
  • Urological Procedures
  • Radiology
  • Other Applications

By End-user

  • Hospitals
  • Ambulatory Surgery Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In December 2022, CATHETRIX, an innovative developer of urinary (Foley) smart catheter fixation devices, announced that it will commercially launch its catheter stabilizer for the prevention of urinary tract infections (UTIs) and accidental Foley catheter extractions at the Arab Health 2023, which will take place January 30-February 2, 2023, in Dubai, UAE.
  • In September 2022, B. Braun Medical Inc. declared that it has acquired the Clik-Fix catheter securement device product portfolio from Starboard Medical, Inc., adding to the company's portfolio of peripheral intravenous (IV) therapy devices.

Why Purchase the Report?

  • To visualize the global Catheter Stabilization Devices- market segmentation based on product, application and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of Catheter Stabilization Devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global Catheter Stabilization Devices market report would provide approximately 61 tables, 64 figures and 195+ Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-user
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological Advancements
      • 4.1.1.2. Increasing Prevalence Of Chronic Diseases
      • 4.1.1.3. XX
    • 4.1.2. Restraints
      • 4.1.2.1. Availability Of Alternative Products
      • 4.1.2.2. XX
    • 4.1.3. Opportunity
      • 4.1.3.1. XX
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Peripheral Catheter Securement Devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Foley Catheter Securement Devices
    • 7.2.4. Nasogastric Tube Securement Devices
    • 7.2.5. Endotracheal Tube Securement Devices
    • 7.2.6. Ventriculoperitoneal Securement Devices
    • 7.2.7. Continuous Nerve Block Catheter Securement Devices
    • 7.2.8. Midlines Securement Devices
  • 7.3. Central Venous Catheter Securement Devices
    • 7.3.1. Portal Securement Devices
    • 7.3.2. PICC Securement Devices
    • 7.3.3. Subclavian Securement Devices
    • 7.3.4. Femoral Securement Devices
    • 7.3.5. Jugular Securement Devices
  • 7.4. Arterial Catheter Securement Devices
  • 7.5. Chest Drainage Tube Securement Devices
  • 7.6. Abdominal Drainage Tube Securement Devices
  • 7.7. Epidural Securement Devices
  • 7.8. All-Site Securement Devices

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiovascular Procedures*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Respiratory Procedures
  • 8.4. Gastric and Oropharyngeal Procedures
  • 8.5. General Surgery
  • 8.6. Urological Procedures
  • 8.7. Radiology
  • 8.8. Other Applications

9. By End-user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 9.1.2. Market Attractiveness Index, By End-user
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgery Clinics
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Russia
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Omron Corporation*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Koninklijke Philips N.V
  • 12.3. 3M
  • 12.4. Allied Healthcare Products, Inc
  • 12.5. Becton, Dickinson and Compan
  • 12.6. Agilent Technologies
  • 12.7. Medline Industries, Inc.
  • 12.8. Briggs Healthcare
  • 12.9. Cathetrix
  • 12.10. GF Health Products, Inc

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services